Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in exercise-induced PAH with connective tissue disease
NCT00864201Phase 3Unknown
- Sponsor
- Hamilton Health Sciences
- Start
- Apr 2009
- Primary completion
- Apr 2010
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bosentan in pulmonary arterial hypertension (PAH), sponsored by Hamilton Health Sciences. Status: unknown.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00864201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00864201.